Association of Pharmacogenetics With Adverse Events of Fluorouracil/Capecitabine in Patients With Cancer

JCO Oncol Pract. 2021 Jul;17(7):453-454. doi: 10.1200/OP.20.01072. Epub 2021 Apr 1.

Authors

Daniel A King¹, Robert B Diasio¹, M Wasif Saif¹

Affiliation

¹ Daniel A. King, MD, PhD, Stanford University, Stanford, CA; Robert B. Diasio, MD, Mayo Clinic Cancer Center, Rochester, MN; and M. Wasif Saif, MD, MBBS, Northwell Health Cancer Institute and Feinstein Institute of Research, Lake Success, NY.

PMID: 33793308
DOI: 10.1200/OP.20.01072

No abstract available

Publication types

Letter
Comment

MeSH terms

Capecitabine / adverse effects
Deoxycytidine
Fluorouracil / adverse effects
Humans
Neoplasms* / drug therapy
Neoplasms* / genetics
Pharmacogenetics*

Substances

Deoxycytidine
Capecitabine
Fluorouracil